The Peter Attia Drive

#65 - Rick Doblin, Ph.D.: MDMA— the creation, scheduling, toxicity, therapeutic use, and changing public opinion of what is possibly the single most important synthetic molecule ever created by our species

18 snips
Aug 5, 2019
Rick Doblin, founder of MAPS, shares his groundbreaking insights on MDMA, revealing its potential to revolutionize PTSD treatment. He dives into the molecule's history, the obstacles leading to its criminalization, and his passionate advocacy for its therapeutic use. The conversation dissects myths surrounding MDMA's safety and touches on the intricacies of current FDA trials for MDMA therapy. With compelling stories and a vision for a compassionate future, this dialogue underscores the importance of reevaluating drug classifications to embrace psychedelic healing.
Ask episode
AI Snips
Chapters
Books
Transcript
Episode notes
ANECDOTE

Doblin's Psychedelic Journey

  • In 1972, Rick Doblin sought guidance for integrating powerful psychedelic experiences.
  • Reading Stan Grof's book on LSD showed him the potential of combining science, spirituality, and therapy.
ANECDOTE

First Encounter with MDMA

  • In 1982, Rick Doblin learned about MDMA from Debbie Harlow at Esalen.
  • He initially underestimated MDMA, thinking it less profound than LSD due to its subtle effects.
INSIGHT

Classifying MDMA

  • MDMA is a psychedelic, but not a classic one like LSD.
  • Terms like "empathogen" and "intactogen" arose to distinguish MDMA in legal battles.
Get the Snipd Podcast app to discover more snips from this episode
Get the app